Published in Vaccine Weekly, September 3rd, 2003
"Literature on genetic screening in the community suggests that people having specific genotypes may either get or protect from infection, for example, malaria, human papillomavirus, and hemophilic influenza, for which vaccines are either already developed or being targeted. In such a situation, the evaluation of the efficacy of vaccine in the community needs to be examined with caution," a scientist in India reports.
"In this paper, I present a method for the estimation of vaccine efficacy (VE) in the presence of genetic...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly